Expected earnings - Adaptimmune Therapeutics plc

November 12, 2025 04:31:12 am

Source: US Earnings Reports

Adaptimmune Therapeutics plc (ADAPY) is expected to report $-0.05 for Q3 2025

Adaptimmune Therapeutics plc

NASDAQ: ADAPY

ADAPY Trading

-16.46% G/L:

$0.033 Last:

260,271 Volume:

$0.0275 Open:

ADAPY Latest News

December 10, 2025 06:00:57 am

December 03, 2025 06:00:36 am

November 26, 2025 06:00:17 am

November 19, 2025 06:00:54 am

Market Cap $6,891,341

Float 203,612,632

Insiders Ownership 38.24%

Institutions 16

Short Percent 31376776%

Industry Biotechnology & Life Sciences

Sector Healthcare

Country GB

City Abingdon